CHIRON DIAGNOSTICS ACS: 180 CARBAMAZEPINE ASSAY

Enzyme Immunoassay, Carbamazepine

CHIRON DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Chiron Diagnostics Corp. with the FDA for Chiron Diagnostics Acs: 180 Carbamazepine Assay.

Pre-market Notification Details

Device IDK964765
510k NumberK964765
Device Name:CHIRON DIAGNOSTICS ACS: 180 CARBAMAZEPINE ASSAY
ClassificationEnzyme Immunoassay, Carbamazepine
Applicant CHIRON DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
ContactWilliam J Pignato
CorrespondentWilliam J Pignato
CHIRON DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
Product CodeKLT  
CFR Regulation Number862.3645 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1996-11-27
Decision Date1997-02-14
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414598482 K964765 000
00630414527178 K964765 000
00630414527161 K964765 000
00630414527154 K964765 000
00630414527147 K964765 000
00630414527130 K964765 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.